Deterioration of Health‐Related Quality of Life Scores under Treatment Predicts Longer Survival

Abstract

Objectives. Baseline health-related quality of life (HRQoL) scores predict survival, which has already been demonstrated in various studies. However, we were interested in whether changes in baseline scores during treatment are also significant predictors of survival. Methods and Materials. We analysed the data of 400 consecutive cancer patients receiving radiochemotherapy. Leading diagnoses were head and neck cancer (34.5%), rectal cancer (24.5%), and lung cancer (13%). HRQoL was studied at baseline, six weeks after therapy and after each completed year after the start of therapy until drop out of the study using the EORTC QLQ-C30 questionnaire. The change score was calculated as the baseline score subtracted from the score after therapy. Statistics included Kaplan-Meier estimates and Cox regression. Results. High global health status (p=0.005) and low pain scores (p=0.040) at baseline were related to favourable overall survival. Change scores of role functioning (p=0.027), global health status (p<0.018), and pain (p<0.001) were predictive of overall survival. Pain was the superior predictor of survival (p=0.001) among all variables and QoL scores studied by multivariate analysis. A deterioration in pain was associated with a 2.8 times higher chance of survival (HR 0.36). Conclusions. Deterioration of HRQoL baseline pain score by cancer treatment is a favourable and superior prognostic factor for survival.

Pilot Study of a Wearable Activity Monitor During Head and Neck Radiotherapy to Predict Clinical Outcomes

“…That said, patients who were taking fewer steps did report greater reductions in their QoL, and we found that a simple cut point (average reduction in 1,000 daily steps from the previous week) was sufficient to highlight this at-risk cohort. Since pretreatment and post-treatment QoL outcomes do predict for survival following head and neck chemoradiotherapy, [12][13][14] there may be a place for WD to monitor patients, especially after treatment when they are not interacting with the health care system on a daily basis. Indeed, remote monitoring of patient activity may work in concert with telemedicine to manage patients after radiotherapy in a cost-effective manner.…”

Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors

“…As mentioned above, the identification of irAE is essential for the patients' safety. There exists a mild correlation between a reduction of quality of life during radiochemotherapy and prolonged survival, which is probably a marker for treatment intensity [36]. However, in case of the occurrence of irAE, ICI treatment frequently has to be stopped and irAE management has to be started.…”

High-density Lipoprotein Cholesterol as a Risk Factor of Health-Related Quality of Life in 50–70-Year-Old Community-Dwelling Women

“…There was also an evaluation of the physical component summary (PCS) with four subcomponents (physical functioning, physical limitations, bodily pain, and general health); and a mental component summary (MCS) with four subcomponents (vitality, social functioning, emotional limitations, and mental health). The quality of life (HRQoL) of the subjects was considered to be good if the SF-36 score was above the median value, and to be poor if the score was under the median value for SF-36 total score, SF-36 PCS, and SF-36 MCS as well as each of the subcomponents [9], [10], [11].…”